1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Genomics Market
2.2. Global Genomics Market, By Product & Services, 2022 (US$ Million)
2.3. Global Genomics Market, By End-User, 2022 (US$ Million)
2.4. Global Genomics Market, By Geography, 2022 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2022

3. Genomics Market: Competitive Analysis
3.1. Market Positioning of Key Genomics Market Vendors
3.2. Strategies Adopted by Genomics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Genomics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Genomics Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Genomics Market: By Product & Services, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Products
5.3.1.1. Instrumentation Technology
5.3.1.1.1. Sequencing Technology
5.3.1.1.2. Microarray
5.3.1.1.3. Polymerase Chain Reaction (PCR)
5.3.1.1.4. Nucleic Acid Extraction and Purification
5.3.1.1.5. Other Technologies
5.3.1.2. Consumables/Reagents
5.3.2. Services
5.3.2.1. Genomic Services
5.3.2.2. Sequencing Services
5.3.2.3. Data Analysis

6. Genomics Market: By End-User, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Academic and Government Research
6.3.2. Hospitals & Clinics
6.3.3. Biopharmaceutical Companies
6.3.4. Clinical Research


7. North America Genomics Market, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Genomics Market: By Product & Services, 2021-2031, USD (Million)
7.3. Genomics Market: By End-User, 2021-2031, USD (Million)
7.4.Genomics Market: By Region, 2021-2031, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
7.4.1.1.1. Genomics Market: By End-User, 2021-2031, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
7.4.1.2.1. Genomics Market: By End-User, 2021-2031, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
7.4.1.3.1. Genomics Market: By End-User, 2021-2031, USD (Million)

8. UK and European Union Genomics Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Genomics Market: By Product & Services, 2021-2031, USD (Million)
8.3. Genomics Market: By End-User, 2021-2031, USD (Million)
8.4.Genomics Market: By Region, 2021-2031, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
8.4.1.1.1. Genomics Market: By End-User, 2021-2031, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
8.4.1.2.1. Genomics Market: By End-User, 2021-2031, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
8.4.1.3.1. Genomics Market: By End-User, 2021-2031, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
8.4.1.4.1. Genomics Market: By End-User, 2021-2031, USD (Million)
8.4.1.5. France
8.4.1.5.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
8.4.1.5.1. Genomics Market: By End-User, 2021-2031, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
8.4.1.6.1. Genomics Market: By End-User, 2021-2031, USD (Million)

9. Asia Pacific Genomics Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Genomics Market: By Product & Services, 2021-2031, USD (Million)
9.3. Genomics Market: By End-User, 2021-2031, USD (Million)
9.4.Genomics Market: By Region, 2021-2031, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
9.4.1.1.1. Genomics Market: By End-User, 2021-2031, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
9.4.1.2.1. Genomics Market: By End-User, 2021-2031, USD (Million)
9.4.1.3. India
9.4.1.3.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
9.4.1.3.1. Genomics Market: By End-User, 2021-2031, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
9.4.1.4.1. Genomics Market: By End-User, 2021-2031, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
9.4.1.5.1. Genomics Market: By End-User, 2021-2031, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
9.4.1.6.1. Genomics Market: By End-User, 2021-2031, USD (Million)

10. Latin America Genomics Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Genomics Market: By Product & Services, 2021-2031, USD (Million)
10.3. Genomics Market: By End-User, 2021-2031, USD (Million)
10.4.Genomics Market: By Region, 2021-2031, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
10.4.1.1.1. Genomics Market: By End-User, 2021-2031, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
10.4.1.2.1. Genomics Market: By End-User, 2021-2031, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
10.4.1.3.1. Genomics Market: By End-User, 2021-2031, USD (Million)

11. Middle East and Africa Genomics Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Genomics Market: By Product & Services, 2021-2031, USD (Million)
11.3. Genomics Market: By End-User, 2021-2031, USD (Million)
11.4.Genomics Market: By Region, 2021-2031, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
11.4.1.1.1. Genomics Market: By End-User, 2021-2031, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
11.4.1.2.1. Genomics Market: By End-User, 2021-2031, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Genomics Market: By Product & Services, 2021-2031, USD (Million)
11.4.1.3.1. Genomics Market: By End-User, 2021-2031, USD (Million)

12. Company Profile
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Merck KGaA
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Danaher Corporation
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. BGI
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Illumina, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Oxford Nanopore Technologies
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Pacific Biosciences of California, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. QIAGEN
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Myriad Genetics, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Eurofins Scientific
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. 23nMe, Inc.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives